694 related articles for article (PubMed ID: 25499305)
1. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
[TBL] [Abstract][Full Text] [Related]
2. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
[TBL] [Abstract][Full Text] [Related]
3. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study.
Schmidt A; Zeller T; Sievert H; Krankenberg H; Torsello G; Stark MA; Scheinert D
J Endovasc Ther; 2014 Feb; 21(1):52-60. PubMed ID: 24502484
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
[TBL] [Abstract][Full Text] [Related]
5. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
7. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
[TBL] [Abstract][Full Text] [Related]
8. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
[TBL] [Abstract][Full Text] [Related]
9. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.
Shammas NW; Shammas GA; Jerin M
J Endovasc Ther; 2013 Dec; 20(6):844-52. PubMed ID: 24325703
[TBL] [Abstract][Full Text] [Related]
10. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
11. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis.
Liao CJ; Song SH; Li T; Zhang Y; Zhang WD
Int Angiol; 2019 Oct; 38(5):365-371. PubMed ID: 31566320
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
[No Abstract] [Full Text] [Related]
14. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
[TBL] [Abstract][Full Text] [Related]
15. Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.
Shammas NW; Shammas GA; Arikat L; Shammas AN; Darrow A; Banerjee A; Rudy B
J Invasive Cardiol; 2017 Jun; 29(6):207-208. PubMed ID: 28570235
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
17. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
Shammas NW; Shammas GA; Banerjee S; Popma JJ; Mohammad A; Jerin M
J Endovasc Ther; 2016 Apr; 23(2):339-46. PubMed ID: 26921281
[TBL] [Abstract][Full Text] [Related]
18. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
[TBL] [Abstract][Full Text] [Related]
19. Initial Results of Standard Balloon Angioplasty Versus Drug Coated Balloon Alone Versus in Association With Laser Excimer Atherectomy in the Treatment of Femoropopliteal Artery In Stent Restenosis (INTACT).
Ducasse E; Sapoval M; Brunet J; Goueffic Y; Lermusiaux P; Caradu C
Eur J Vasc Endovasc Surg; 2024 May; 67(5):850-851. PubMed ID: 38301872
[No Abstract] [Full Text] [Related]
20. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]